Neuroone Medical Technologies (NMTC) Change in Intangibles (2018)

Neuroone Medical Technologies (NMTC) reported Change in Intangibles of $146709.0 for Q2 2018, up 59.97% sequentially from $91709.0 in Q1 2018.

Neuroone Medical Technologies (NMTC) Change in Intangibles (2018) Analysis & Trends

Neuroone Medical Technologies has disclosed Change in Intangibles across 1 years of filings, most recently posting $146709.0 for Q2 2018.

Quarterly Change in Intangibles changed N/A year-over-year to $146709.0 in Q2 2018, while the trailing twelve-month figure through Sep 2019 was $238418.0 (changed N/A YoY) and the FY2019 annual result came in at $65000.0, up 18.18% from the prior year.
Change in Intangibles advanced to $146709.0 in Q2 2018, from $91709.0 in the prior quarter.
Across five years, Change in Intangibles topped out at $146709.0 in Q2 2018 and bottomed at $91709.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-31.61 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Neuroone Medical Technologies	26.73 Mn	23.93 Mn	990,264.00	-

Download Data